Literature DB >> 26576584

Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment.

Liliana Chiorean1, Adrian Bartos2, Doris Pelau3, Dana Iancu3, Tudor Ciuleanu4, Rares Buiga5, Irinel Oancea6, Angelica Mangrau6, Cornel Iancu7, Radu Badea8.   

Abstract

Neuroendocrine carcinoma of the gallbladder is an uncommon disease. We present the case of a 45-year-old woman with a mass located in the gallbladder, whose diagnosis was based on contrast-enhanced ultrasound and magnetic resonance imaging. The tumor involved the liver and retroperitoneum, and was histopathologically confirmed by liver biopsy as a neuroendocrine tumor grade 3. The patient received chemotherapy with good response, followed by surgery with cholecystectomy and partial hepatectomy.

Entities:  

Keywords:  Contrast-enhanced ultrasound; Gallbladder; Imaging; Neuroendocrine tumors; Ultrasound

Mesh:

Substances:

Year:  2014        PMID: 26576584     DOI: 10.1007/s10396-014-0585-1

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  37 in total

1.  Large cell neuroendocrine carcinoma of the gallbladder: report of two cases.

Authors:  M Papotti; P Cassoni; A Sapino; G Passarino; J E Krueger; J Albores-Saavedra
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Authors:  Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

Review 3.  Treatment options for unresectable neuroendocrine liver metastases.

Authors:  Biku Joseph John; Brian R Davidson
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2012-06       Impact factor: 3.869

Review 4.  Primary hepatic carcinoid tumor: case report and review of 53 cases.

Authors:  M Iwao; M Nakamuta; M Enjoji; H Kubo; T Fukutomi; Y Tanabe; H Nishi; K I Taguchi; K Kotoh; H Nawata
Journal:  Med Sci Monit       Date:  2001 Jul-Aug

Review 5.  Malignant carcinoid of the gallbladder: third reported case and review of the literature.

Authors:  G J Bosl; A Yagoda; L H Camara-Lopes
Journal:  J Surg Oncol       Date:  1980       Impact factor: 3.454

6.  Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results.

Authors:  E M Jung; C J Ross; J Rennert; M N Scherer; S Farkas; P von Breitenbuch; A A Schnitzbauer; P Piso; P Lamby; C Menzel; A G Schreyer; S Feuerbach; H J Schlitt; M Loss
Journal:  Clin Hemorheol Microcirc       Date:  2010       Impact factor: 2.375

7.  Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.

Authors:  E Seregni; L Ferrari; E Bajetta; A Martinetti; E Bombardieri
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

Review 8.  From the archives of the AFIP. Benign tumors and tumorlike lesions of the gallbladder and extrahepatic bile ducts: radiologic-pathologic correlation. Armed Forces Institute of Pathology.

Authors:  Angela D Levy; Linda A Murakata; Robert M Abbott; Charles A Rohrmann
Journal:  Radiographics       Date:  2002 Mar-Apr       Impact factor: 5.333

9.  Primary endocrinomas (carcinoids and variant neoplasms) of the gallbladder. A statistical evaluation of 138 reported cases.

Authors:  J Soga
Journal:  J Exp Clin Cancer Res       Date:  2003-03

10.  Prognostic variables in patients with gastrointestinal carcinoid tumours.

Authors:  E W McDermott; B Guduric; M F Brennan
Journal:  Br J Surg       Date:  1994-07       Impact factor: 6.939

View more
  2 in total

Review 1.  Neuroendocrine tumors of the gallbladder.

Authors:  Chunyuan Niu; Shupeng Wang; Qingchun Guan; Xuekang Ren; Bai Ji; Yahui Liu
Journal:  Oncol Lett       Date:  2020-03-12       Impact factor: 2.967

2.  Primary Small Cell Neuroendocrine Tumour of Gallbladder Presenting as Pyrexia of Unknown Origin.

Authors:  Arkadeep Dhali; Sukanta Ray; Gopal Krishna Dhali
Journal:  Cureus       Date:  2021-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.